We provide professional support in In-vitro Fertilization (IVF) Department.
In-vitro fertilization was performed in 1973 for the
first time, but pregnancy did not develop with the embryo obtained. In July
1978, “Louise Brown”, the world’s first test-tube baby, was born in
UK. Thereafter, hormone drugs have been developed for use in ovulation
therapies. But the real progress was made with the invention of ICSI
(micro-injection) in 1996. Therefore, the rate of success in in-vitro
fertilization applications has increased, and a significant distance has been
covered in male infertility problems.
Ovulation problems are the most common cause of female
infertility. Polycystic ovary syndrome is the primary reason of ovulation
irregularity in women. Polycystic ovary syndrome (PCOS) which is one of the
most common reasons of infertility alongside menstrual irregularity and which
is caused by ovarian cysts may also be accompanied by hirsutism and weight
gain. Apart from that, the excess of prolactin, a hormone which is secreted by
the pituitary gland in the brain and normally promotes lactation has also a
negative effect on ovulation. In such a case, prolactin secretion is reduced by
medication therapy and the woman may again ovulate regularly.
Similarly when the woman’s thyroid gland functions are insufficient, ovulation
can be restored by thyroid hormone replacement therapy. Excessive exercising or
dieting by the woman is another factor which may suppress ovulation and cause
menstrual irregularity.
In general, ovulation problems are attempted to be corrected by medication
therapy.
Since sperm production is under the control of FSH and LH
hormones secreted from the pituitary gland in the brain, irregular secretion of
these hormones may lead to infertility.
Couples who apply to our IVF center to have a child, a treatment of the cause is first
recommended. If unexplained infertility exists, general treatments that aid
reproduction can be applied. These treatments are as follows:
Ultrasound
examinations of the patient are performed on the 2nd or 3rd day of
menstruation. If the ultrasound shows that there are no obstacles to start treatment
in the uterine or ovaries, oral medications are given to the patient to induce
ovulation. In this period of time, ultrasound follow up is performed at certain
intervals.
An institution that fueled dozens of worthwhile projects in Turkey, Anadolu Foundation made another dream real by founding Anadolu Medical Center.
Relying on the valuable heritage of Anatolia that boasts of thousands of years of medical knowledge and was home to many valuable people of medicine, our hospital uses this knowledge to contribute to human health.
Working in strategic cooperation with Johns Hopkins Medicine for the improvement of education and quality, our hospital provides services in all branches including in particular, oncologic sciences, cardiovascular health, gynecology and IVF, neurological sciences, surgical sciences, internal medicine, diagnosis and imaging.
Established on an area of 188.000 square meters and an indoor area of 50 thousand square meters with a capacity of 201 beds, our hospital provides services with JCI (Joint Commission International) accreditation, ESMO (European Society for Medical Oncology), ISO (18001, 14001 and 9001) certifications.
Anadolu Medical Center continues to provide healthcare services also at Ataşehir with its Outpatient Clinic. Procedural archives of patients who receive services at the Outpatient Clinic are kept in the virtual environment.
Having started to render service in June 2010 within the structure of the hospital, the Bone Marrow Transplantation Center performs bone marrow transplants for 22 patients at the same time. Our patients are always the number one priority at our hospital. For this reason, we give value to the needs and expectations of our patients, and make every effort to ensure that they have a peaceful treatment process and feel at home.
©2021 All rights reserved BookingDoctors™.
